Saturday, 12 July 2025
  
Login

Australia's most trusted
source of pharma news

Saturday, 12 July 2025
News

Patient advocate death 'devastating'

Posted 27 November 2024 PM

Tributes are pouring in from across industry following the death of Russell Conley who stepped down as the CEO of the GI Cancer Institute in September after 22 years with the organisation - sadly succumbing to the disease he spent his entire career fighting. 

Conley received his diagnosis two years ago, undergoing gruelling treatments but remaining in his beloved job for as long as he could to help patients, finally stepping down less than two months ago for health reasons.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (11)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.